Evidence map›Paper›PMID 38346293›Full record

ReviewAnnual review of clinical psychology2024

Mobile Health Interventions for Substance Use Disorders.

Michael S Businelle, Olga Perski, Emily T Hébert, Darla E Kendzor

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Annual review of clinical psychology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07067151 (Use of Noninvasive Wearables Biomonitoring to Detect Pre-Smoking, Smoking, And Post-Smoking Stages), which is not on this map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07067151 enrolling by invitationnot on this mapstarted 2026, after this paper: background citation

Use of Noninvasive Wearables Biomonitoring to Detect Pre-Smoking, Smoking, And Post-Smoking Stages: An Observational Laboratory Study

TypeobservationalSponsorNational Institute on Minority Health and Health Disparities (NIMHD)Ran2026 to 2028Enrolled30ConditionsSmoking
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. State Medicaid Telehealth Policies and Rates of Alcohol and Substance Use Treatment at Federally Qualified Health Centers: Does Modality Matter?Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Michael S BusinelleTSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA; email: Michael-businelle@ouhsc.edu.
Olga PerskiHerbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA.
Emily T HébertDepartment of Health Promotion and Behavioral Sciences, University of Texas Health Science Center at Houston, Austin, Texas, USA.
Darla E KendzorTSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA; email: Michael-businelle@ouhsc.edu.
University of Oklahoma Health Sciences Center · USHuman Longevity (United States) · USThe University of Texas Health Science Center at Houston · US

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI James F Papin · 2018 to 2026
$27.1M
Using Machine Learning to Develop Just-in-Time Adaptive Interventions for Smoking CessationR00DA046564 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HEBERT, EMILY TAYLOR · 2021 to 2023
$747k
NCI NIH HHS P30 CA225520NIDA NIH HHS R00 DA046564
6 · The paper itself

Abstract

Substance use disorders (SUDs) have an enormous negative impact on individuals, families, and society as a whole. Most individuals with SUDs do not receive treatment because of the limited availability of treatment providers, costs, inflexible work schedules, required treatment-related time commitments, and other hurdles. A paradigm shift in the provision of SUD treatments is currently underway. Indeed, with rapid technological advances, novel mobile health (mHealth) interventions can now be downloaded and accessed by those that need them anytime and anywhere. Nevertheless, the development and evaluation process for mHealth interventions for SUDs is still in its infancy. This review provides a critical appraisal of the significant literature in the field of mHealth interventions for SUDs with a particular emphasis on interventions for understudied and underserved populations. We also discuss the mHealth intervention development process, intervention optimization, and important remaining questions.

Indexed as

Substance-Related DisordersTelemedicineHumansalcoholdigital healtheHealthhealth disparitiesjust-in-time adaptive interventionsmHealthsmartphonesubstance use disorderstobacco

Identifiers

PMID38346293
PMCPMC11855402
OpenAlexW4391756959

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.